Story
European Equities Challenge U.S. Market Supremacy in 2026 Performance

Summary
European stock benchmarks are unexpectedly matching or outperforming their U.S. counterparts year-to-date, as investors weigh high U.S. valuations against Europe's improving earnings and stabilizing trade relations.
A long-held narrative of U.S. market dominance is being challenged in 2026, with key European indices posting returns that rival and in some cases exceed those of major American benchmarks. This convergence reflects a significant shift in underlying market drivers, from a rotation within U.S. technology stocks to a quiet resurgence in European corporate fundamentals.
A Tale of Two Markets
Year-to-date performance figures highlight the changing landscape. As of July 29, 2026, the UK's FTSE 100 has gained +9.72%, outpacing the U.S. S&P 500's gain of +8.01%. The pan-European Euro Stoxx 50 is nearly in lockstep with its American peer, up +8.22%.
This contrasts sharply with recent years of U.S. exceptionalism, driven largely by mega-cap technology stocks. The performance gap has narrowed significantly, prompting a re-evaluation of regional opportunities and risks among global investors.
U.S. Market Grapples with Internal Rotation
The headline strength of the S&P 500 masks considerable internal divergence. The so-called "Magnificent 7" tech giants have seen their collective performance slow, while value-oriented indices like the Dow Jones Industrial Average (+9.65% YTD) have shown greater resilience.
A key concern for investors is the sustainability of massive AI-related capital expenditures. A Reuters analysis projects that by 2027, Big Tech's combined capex could exceed its operating cash flow growth by $534 billion. This pressure on free cash flow is a central theme, alongside near-term volatility risk from the Federal Reserve's policy decisions. Despite these headwinds, the bull case for the U.S. is supported by strong Q2 consensus earnings per share (EPS) growth of +26% year-over-year.
AdEurope's Resurgence on Three Fronts
Europe's competitive performance is attributed to several underappreciated factors:
- Improved Trade Outlook: Sentiment has improved following the EU-US trade deal of July 2025, with 51% of U.S. companies in Europe now expecting stable transatlantic relations, a significant reversal from the 89% pessimism recorded in January 2025.
- Broadening Earnings Growth: Barclays reports that European corporate pre-announcements have been positive for two consecutive quarters, a first since 2021. The bank forecasts +12% EPS growth for European companies for the full year 2026.
- Favorable Investor Positioning: According to Citi, the FTSE 100 has a technical setup for a potential "short squeeze," as most short positions are currently unprofitable. The index's composition—heavy in energy, financials, and mining—is also well-aligned with the current macroeconomic environment of elevated commodity prices.
The Valuation Gap
The most significant structural advantage for Europe remains valuation. U.S. equities trade at a forward price-to-earnings (P/E) ratio of approximately 29x, a substantial premium to European markets, which trade in the low-to-mid teens. Goldman Sachs notes that U.S. household equity holdings as a share of financial assets have surpassed post-WWII highs, a potential signal of market concentration.
While the U.S. remains the primary market for direct exposure to the AI investment cycle, Europe is increasingly viewed as an attractive alternative for investors seeking value, cyclical exposure to commodities and financials, and a beneficiary of stabilizing global trade.
Read next
More on Stocks
CarMax Stock Surges on Strong Earnings Beat and Sales Rebound
CarMax reported fiscal second-quarter results that far exceeded analyst expectations, driven by a 13% jump in same-store sales and plans to resume its share buyback program.

Netflix Stock Gains After Deutsche Bank Upgrades to 'Buy'
Shares of the streaming giant rose after Deutsche Bank upgraded the stock to 'Buy' from 'Hold,' setting a $95 price target and citing a valuation opportunity following a prolonged selloff.

Amazon, GoodRx Prescription Subscriptions Gain Traction Amid Rising US Healthcare Costs
Amazon and GoodRx are seeing significant growth in their prescription drug subscription services as consumers seek alternatives to rising insurance premiums and out-of-pocket expenses.

SEC Proposes Scaling Back Sarbanes-Oxley Auditor Requirements
The U.S. Securities and Exchange Commission plans to reduce the number of companies required to have external auditors verify internal financial controls, a key post-Enron investor protection.